KoreaMed Synapse (original) (raw)

1. Bollinger RR, Cho WH. Organ allocation for transplantation in the USA and Korea: the changing roles of equity and utility. Yonsei Med J. 2004; 45:1035–1042. PMID: 15627294.

2. Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, et al. Survival rates among patients awaiting deceased donor liver transplants at a single high-volume Korean center. Transplant Proc. 2013; 45:2995–2996. PMID: 24157021.

3. Min SI, Ahn C, Han DJ, Kim SI, Chung SY, Lee SK, et al. To achieve national self-sufficiency: recent progresses in deceased donation in Korea. Transplantation. 2015; 99:765–770. PMID: 25226175.

4. Lee SG, Moon DB, Hwang S, Ahn CS, Kim KH, Song GW, et al. Liver transplantation in Korea: past, present, and future. Transplant Proc. 2015; 47:705–708. PMID: 25891715.

5. Jung BH, Hwang S, Song GW, Jung DH, Ha TY, Park GC, et al. Updated status of deceased-donor liver graft allocation for high-urgency adult patients in a Korean high-volume liver transplantation center. Transplant Proc. 2015; 47:580–583. PMID: 25891690.

6. Korean Association for the Study of the Liver. KASL clinical practice guidelines: management of chronic hepatitis B. Clin Mol Hepatol. 2016; 22:18–75. PMID: 27044762.

7. Moon DB, Lee SG, Hwang S, Kim KH, Ahn CS, Ha TY, et al. Toward more than 400 liver transplantations a year at a single center. Transplant Proc. 2013; 45:1937–1941. PMID: 23769078.

8. Massie AB, Chow EK, Wickliffe CE, Luo X, Gentry SE, Mulligan DC, et al. Early changes in liver distribution following implementation of Share 35. Am J Transplant. 2015; 15:659–667. PMID: 25693474.

9. Washburn K, Harper A, Baker T, Edwards E. Changes in liver acceptance patterns after implementation of Share 35. Liver Transpl. 2016; 22:171–177. PMID: 26437266.

10. Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, et al. Liver retransplantation for adult recipients. Korean J Hepatobiliary Pancreat Surg. 2013; 17:1–7. PMID: 26155206.

11. Oh SH, Kim KM, Kim DY, Song SM, Kim T, Hwang S, et al. Clinical experience of more than 200 cases of pediatric liver transplantation at a single center: improved patient survival. Transplant Proc. 2012; 44:484–486. PMID: 22410052.

12. Cuenca AG, Kim HB, Vakili K. Pediatric liver transplantation. Semin Pediatr Surg. 2017; 26:217–223. PMID: 28964477.

13. Moon DB, Lee SG, Kang WH, Song GW, Jung DH, Park GC, et al. Adult living donor liver transplantation for acute-on-chronic liver failure in high-model for end-stage liver disease score patients. Am J Transplant. 2017; 17:1833–1842. PMID: 28097804.

14. Yadav SK, Saraf N, Saigal S, Choudhary NS, Goja S, Rastogi A, et al. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients. Clin Transplant. 2017; 31:DOI: 10.1111/ctr.13006.

15. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl. 2004; 10:7–15. PMID: 14755772.

16. Ben-Haim M, Carmiel M, Katz P, Shabtai E, Oren R, Nakache R. Is the model of end-stage liver disease (MELD) valid in Israel? A critical analysis of liver transplant waiting list mortality. Isr Med Assoc J. 2006; 8:605–609. PMID: 17058408.

17. Castro RS, Deisanti D, Seva-Pereira T, Almeida JR, Yamanaka A, Boin IF, et al. Survival before and after model for end-stage liver disease score introduction on the Brazilian liver transplant waiting list. Transplant Proc. 2010; 42:412–416. PMID: 20304153.

18. Chaib E, Figueira ER, Brunheroto A, Gatti AP, Fernandes DV, D'Albuquerque LA. Does the patient selection with MELD score improve short-term survival in liver transplantation? Arq Bras Cir Dig. 2013; 26:324–327. PMID: 24510043.

19. Asrani SK, Kim WR. Model for end-stage liver disease: end of the first decade. Clin Liver Dis. 2011; 15:685–698. PMID: 22032523.